Global Human reproductive technologies market - 2013 - 2019

Transparency Market Research Human Reproductive Technologies Market - Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 - 2019

Published Date 14-April-2014

125 Page Report

Buy Now

Request Sample

Press Release Human Reproductive Technologies Market Will Reach US$27.1 Billion by 2019: Transparency Market Research Transparency Market Research State Tower, 90, State Street, Suite 700.

Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

Human Reproductive Technologies Market

REPORT DESCRIPTION

Human Reproductive Technologies Market - Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 - 2019 In the new report published by Transparency Market Research “Human Reproductive Technologies Market Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 - 2019,� the global human reproductive market technologies was worth US$23.0 billion in 2012. However, according to some recent research and statistics the overall human reproductive technologies market is growing at a CAGR 2.2% from 2013 to 2019 and is expected to reach US$27.1 billion in 2019.

Browse the full report at http://www.transparencymarketresearch.com/human-reproductive-technologies-market.html In order to provide a thorough analysis of the overall competitive scenario in the global human reproductive technologies market, this report covers every aspect of the market and analyzes it in terms of treatment technologies, drugs, and various devices that are used to assist and control human reproduction.

Considering the human reproductive technologies market on the basis of market segmentation, the global market is divided into two major segments: contraceptive technologies and infertility treatments. The report involves the study of several providers and manufacturers of contraceptive technologies and infertility solutions too.

The contraceptive technologies market is further classified into contraceptive devices and drugs. The contraceptive devices market is sectioned into female contraceptive devices and male contraceptive devices (condoms), while, the contraceptive drugs market comprises topical contraceptives, contraceptive injectables, and oral contraceptive pills.

In 2012, the global contraceptives market was worth US$16.0 billion; however, presently, the market is expected to grow at a CAGR of 5.5% from 2013 to 2019. Among the varied contraceptive drugs, the oral contraceptive pills market held the highest revenue in 2012 and thus, led the overall contraceptives

Transparency Market Research

2

Human Reproductive Technologies Market

market in the same year. The growth was also mainly due to rising awareness about oral contraceptive pills among population through advertisements. People can buy drugs over-the-counter as well.

At the same time, the contraceptive devices market - male condoms was considered to be the largest market segment due to awareness among population and increased accessibility with ease of use.

We are currently offering a flat 15% discount on all purchases until end of the March 2015! http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1876 Likewise, the report also provides details about the infertility technologies market which is broadly analyzed with respect to types of treatment procedures and drugs. The types of infertility treatment methods studied in the report include zygote intrafallopian transfer (ZIFT), intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI), in vitro fertilization (IVF), and gamete intrafallopian transfer (GIFT).

Furthermore, with respect to infertility drugs, the market witnesses three primary classes involving certain leading brands (by sales), namely, androgens, gonadotropins, and erectile dysfunction. Some of the other drugs analyzed in this study report include AndroGel, Viagra, Gonal-f, Cialis, Follistim AQ, Testim, and Levitra/Staxyn.

Among all the aforementioned drugs, Viagra was the largest drug brand (by revenue) in 2012 and has been a renowned and approved brand by the U.S. FDA, since 1998. Owing to increasing incidences of erectile dysfunction in male infertility, Viagra is still at a commanding position in the global infertility market. Moreover, for testosterone deficiency, AndroGel is the most preferred drug for the treatment, and Gonal-f under the gonadotropin class is a widely prescribed brand to achieve better results for infertility issues.

The report study observes some of the main players in the global human reproductive technologies market which include Merck Serono, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Abbott Laboratories, Bayer AG, Watson Pharmaceuticals, Pfizer, Inc., and Reckitt Benckiser. Generic manufacturers such as Par Pharmaceuticals and Watson Pharmaceuticals are expected to penetrate the global human reproductive technologies market with their new generic versions by 2015.

North America was a dominant player in the global human reproductive technologies market in 2012 and this region is further expected to maintain its market position till 2019. Nevertheless, the Asia-Pacific

Transparency Market Research

3

Human Reproductive Technologies Market

contraceptive technologies market is also growing rapidly mainly due to the rising awareness and acceptance of human reproductive technologies in this region. The growth rate is estimated to be 6.9% CAGR from 2013 to 2019.

The global human reproductive technologies market is categorized into the following segments: Human Reproductive Technologies Market, by Infertility Drugs •

Gonal-f (recombinant follitropin alfa)

•

Follistim AQ (follitropin beta)

•

AndroGel (testosterone)

•

Testim (testosterone)

•

Viagra (sildenafil citrate)

•

Cialis (tadalafil)

•

Levitra/Staxyn (vardenafil)

Human Reproductive Technologies Market, by Infertility Procedures •

In Vitro Fertilization (IVF)

•

Intracytoplasmic Sperm Injection (ICSI)

•

Zygote Intrafallopian Transfer (ZIFT)

•

Gamete Intrafallopian Transfer (GIFT)

•

Intrauterine Insemination (IUI)

Transparency Market Research

4

Human Reproductive Technologies Market

Human Reproductive Technologies Market, by Contraceptive Technologies •

Drugs

•

Oral Contraceptive Pills

•

Contraceptive Injectables

•

Topical Contraceptives

•

Devices

•

Male Contraceptive Devices (Male Condoms)

•

Female Contraceptive Devices

Human Reproductive Technologies Market, by Geography •

North America

•

Europe

•

Asia-Pacific

•

Rest of the World (RoW)

Browse More Report on Pharmaceuticals Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

TABLE OF CONTENT

Chapter 1 Introduction 1.1 Report Description

Transparency Market Research

5

Human Reproductive Technologies Market

1.2 Market Segmentation 1.4 Research Methodology 1.5 List of Abbreviations

Chapter 2 Executive Summary 2.1 Market Snapshot: Global Human Reproductive Technologies Market 2.2 Comparative Analysis: Global Human Reproductive Technologies Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 Market Overview 3.1 Introduction and Market Definition 3.1.1 Infertility Causative Factors 3.2 Market Drivers 3.2.1 Delay in Conception 3.2.2 Rise in the Number of Infertile Population 3.2.3 Increasing Prevalence of Worldwide Obesity 3.2.4 Lifestyle Hazards such as Smoking, Stress and Pollution 3.2.5 Rising Prevalence of Unwanted Pregnancies and High Global Prevalence of Women with Unmet Contraceptive Needs 3.2.6 Government and NGO Initiatives to Promote Contraceptive Products 3.2.7 Implementation of the Patient Protection Act or the Affordable Care Act 3.3 Market Restraints 3.3.1 Limited Insurance Coverage 3.3.2 Economic and Social Factors

Transparency Market Research

6

Human Reproductive Technologies Market

3.3.3 Side Effects Associated with the Use of Contraceptive Drugs and Devices 3.4 Market Opportunities 3.4.1 Rise in Medical Tourism 3.4.2 Government Support for Infertility Procedures 3.4.3 Presence of Strong Contraceptives Pipeline 3.5 Porter’s Five Forces Analysis for the Global Human Reproductive Technologies Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of New Entrants 3.5.4 Threat of Substitutes 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis: Global Human Reproductive Technologies Market, by Geography

Chapter 4 Global Human Reproduction Technologies Market, by Infertility Treatment 4.1 Overview 4.2 Infertility Drugs 4.2.1 Global Infertility Drugs Market Revenue, by Brand, 2011 – 2019 (USD Million) 4.2.2 Gonal-f 4.2.2.1 Global Gonal-f Market Revenue, 2011 – 2019 (USD Million) 4.2.3 Follistim AQ 4.2.3.1 Global Follistim AQ Market Revenue, 2011 – 2019 (USD Million) 4.2.4 AndroGel 4.2.4.1 Global AndroGel Market Revenue, 2011 – 2019 (USD Million)

Transparency Market Research

7

Human Reproductive Technologies Market

4.2.5 Testim 4.2.5.1 Global Testim Market Revenue, 2011 – 2019 (USD Million) 4.2.6 Viagra 4.2.6.1 Global Viagra Market Revenue, 2011 – 2019 (USD Million) 4.2.7 Cialis 4.2.7.1 Global Cialis Market Revenue, 2011 – 2019 (USD Million) 4.2.8 Levitra/Staxyn 4.2.8.1 Global Levitra/Staxyn Market Revenue, 2011 – 2019 (USD Million) 4.3 Infertility Treatment/Assisted Reproductive Technologies (ART) 4.3.1 Global Infertility Treatment/ART Procedures Market Forecast, by Procedures, 2011 – 2019 (Number of Procedures) 4.3.2 In Vitro Fertilization (IVF) 4.3.2.1 Global IVF Procedures Market Forecast, 2011 – 2019 (Number of Procedures) 4.3.3 Intracytoplasmic Sperm Injection (ICSI) 4.3.3.1 Global ICSI Procedures Market Forecast, 2011 – 2019 (Number of Procedures) 4.3.4 Zygote Intrafallopian Transfer (ZIFT) 4.3.4.1 Global ZIFT Procedures Market Forecast, 2011 – 2019 (Number of Procedures) 4.3.5 Gamete Intrafallopian Transfer (GIFT) 4.3.5.1 Global GIFT Procedures Market Forecast, 2011 – 2019 (Number of Procedures) 4.3.6 Intrauterine Insemination (IUI) 4.3.6.1 Global IUI Procedures Market Forecast, 2011 – 2019 (Number of Procedures)

Chapter 5 Global Human Reproductive Technologies Market, by Contraceptive Technologies 5.1 Overview

Transparency Market Research

8

Human Reproductive Technologies Market

5.1.1 Global Contraceptives Market Revenue, by Product Type, 2011 - 2019 (USD Million) 5.2 Contraceptive Drugs 5.2.1 Global Contraceptive Drugs Market Revenue, by Type, 2011 – 2019 (USD Million) 5.2.2 Oral Contraceptive Pills 5.2.2.1 Global Oral Contraceptive Pills Market Revenue, 2011 – 2019 (USD Million) 5.2.3 Contraceptive Injectables 5.2.3.1 Global Contraceptive Injectables Market Revenue, 2011 – 2019 (USD Million) 5.2.4 Topical Contraceptives 5.2.4.1 Global Topical Contraceptives Market Revenue, 2011 – 2019 (USD Million) 5.3 Contraceptive Devices 5.3.1 Global Contraceptive Devices Market Revenue, by Type, 2011 – 2019 (USD Million) 5.3.2 Male Contraceptive Devices (Male Condoms) 5.3.2.1 Global Male Contraceptive Devices (Male Condoms) Market Revenue, 2011 – 2019 (USD Million) 5.3.3 Female Contraceptive Devices 5.3.3.1 Global Female Contraceptive Devices Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Global Human Reproductive Technologies Market Revenue, by Geography 6.1 Overview 6.2 North America 6.2.1 North America Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million) 6.2.2 North America Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million) 6.3 Europe

Transparency Market Research

9

Human Reproductive Technologies Market

6.3.1 Europe Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million) 6.3.2 Europe Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million) 6.4 Asia-Pacific 6.4.1 Asia-Pacific Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million) 6.4.2 Asia-Pacific Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million) 6.5 Rest of the World (RoW) 6.5.1 RoW Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million) 6.5.2 RoW Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Recommendations

Chapter 8 Company Profiles 8.1 Abbott Laboratories, Inc. 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Actavis, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview

Transparency Market Research

10

Human Reproductive Technologies Market

8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 Bayer AG 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 Church & Dwight, Co. Inc. 8.4.1 Company Profile 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.5 Recent Developments 8.5 Cook Medical, Inc. 8.5.1 Company Overview 8.5.2 Product Portfolio 8.5.3 Business Strategies 8.5.4 Recent Developments 8.6 Ferring International Center S.A. 8.6.1 Company Overview 8.6.2 Product Portfolio

Transparency Market Research

11

Human Reproductive Technologies Market

8.6.3 Business Strategies 8.6.4 Recent Developments 8.7 Johnson & Johnson 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Merck & Co., Inc. 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Merck Serono 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments 8.10 Pfizer, Inc. 8.10.1 Company Overview 8.10.2 Financial Overview

Transparency Market Research

12

Human Reproductive Technologies Market

8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.5 Recent Developments 8.11 Reckitt Benckiser Group plc 8.11.1 Company Overview 8.11.2 Financial Overview 8.11.3 Product Portfolio 8.11.4 Business Strategies 8.11.5 Recent Developments 8.12 Teva Pharmaceutical Industries Ltd. 8.12.1 Company Overview 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Business Strategies 8.12.5 Recent Developments 8.13 Warner Chilcott plc 8.13.1 Company Overview 8.13.2 Financial Overview 8.13.3 Product Portfolio 8.13.4 Business Strategies 8.13.5 Recent Developments

Transparency Market Research

13

Human Reproductive Technologies Market

Browse Full Press Release @ http://www.transparencymarketresearch.com/pressrelease/human-reproductive-technologiesmarket.htm

About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.

Contact

Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse The Market Research Blog : https://marketsresearchindustry.wordpress.com/

Transparency Market Research

14